Terms: = Breast cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG
57 results:
1. PPARγ antagonists induce aromatase transcription in adipose tissue cultures.
Ardenkjær-Skinnerup J; Saar D; Petersen PSS; Pedersen M; Svingen T; Kragelund BB; Hadrup N; Ravn-Haren G; Emanuelli B; Brown KA; Vogel U
Biochem Pharmacol; 2024 Apr; 222():116095. PubMed ID: 38423186
[TBL] [Abstract] [Full Text] [Related]
2. Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate breast cancer Progression in a TAMs-Leading Immune Microenvironment.
Xu NY; Li J; Wang ML; Chen XY; Tang R; Liu XQ
ACS Appl Mater Interfaces; 2024 Mar; 16(9):11275-11288. PubMed ID: 38383056
[TBL] [Abstract] [Full Text] [Related]
3. cancer Cells Promote Immune Regulatory Function of Macrophages by Upregulating Scavenger Receptor MARCO Expression.
Gu C; Wiest M; Zhang W; Halder K; Zurawski S; Zurawski G; Joo H; Oh S
J Immunol; 2023 Jul; 211(1):57-70. PubMed ID: 37212598
[TBL] [Abstract] [Full Text] [Related]
4. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract] [Full Text] [Related]
5. Asiaticoside hampers epithelial-mesenchymal transition by promoting pparg expression and suppressing P2RX7-mediated TGF-β/Smad signaling in triple-negative breast cancer.
Huang X; Jia Z; Li X; Hu Z; Yu X; Xia J
Phytother Res; 2023 May; 37(5):1771-1786. PubMed ID: 36444395
[TBL] [Abstract] [Full Text] [Related]
6. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in breast cancer Cells.
Hernández-Quiles M; Baak R; Orea-Soufi A; Borgman A; den Haan S; Sobrevals Alcaraz P; Jongejan A; van Es R; Velasco G; Vos H; Kalkhoven E
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142452
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy.
Hermawan A; Putri H
BMC Genom Data; 2022 Sep; 23(1):72. PubMed ID: 36114448
[TBL] [Abstract] [Full Text] [Related]
8. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation.
Yadav DK; Sharma A; Dube P; Shaikh S; Vaghasia H; Rawal RM
Comput Biol Med; 2022 Oct; 149():106036. PubMed ID: 36096037
[TBL] [Abstract] [Full Text] [Related]
9. breast cancer Stem Cells-derived Extracellular Vesicles Affect pparg Expression by Delivering MicroRNA-197 in breast cancer Cells.
Li L; Xiong Y; Wang N; Zhu M; Gu Y
Clin Breast Cancer; 2022 Jul; 22(5):478-490. PubMed ID: 35279406
[TBL] [Abstract] [Full Text] [Related]
10. A robust method for collider bias correction in conditional genome-wide association studies.
Mahmoud O; Dudbridge F; Davey Smith G; Munafo M; Tilling K
Nat Commun; 2022 Feb; 13(1):619. PubMed ID: 35110547
[TBL] [Abstract] [Full Text] [Related]
11. Alpha1-antitrypsin combined fatty acids induced angiopoietin-like protein 4, expression in breast cancer: A pilot study.
Preethika A; Suchetha Kumari N; Sandeep A; Shetty J
Chem Phys Lipids; 2022 Mar; 243():105175. PubMed ID: 35063423
[TBL] [Abstract] [Full Text] [Related]
12. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract] [Full Text] [Related]
13. Diet and
Tran L; Bobe G; Arani G; Zhang Y; Zhang Z; Shannon J; Takata Y
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33477496
[TBL] [Abstract] [Full Text] [Related]
14. breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by pparg.
Wilson HE; Stanton DA; Rellick S; Geldenhuys W; Pistilli EE
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C577-C590. PubMed ID: 33439777
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of breast cancer.
Zhang Y; Gao Y; Li Y; Zhang X; Xie H
Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
[TBL] [Abstract] [Full Text] [Related]
16. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
[TBL] [Abstract] [Full Text] [Related]
17. Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
Van Poznak C; Reynolds EL; Estilo CL; Hu M; Schneider BP; Hertz DL; Gersch C; Thibert J; Thomas D; Banerjee M; Rae JM; Hayes DF
Oral Dis; 2022 Jan; 28(1):193-201. PubMed ID: 33274559
[TBL] [Abstract] [Full Text] [Related]
18. Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan.
Wang Y; Zhang X; Xie X; Chen W; Li M; Diao D; Dang C
Cancer Biol Ther; 2020 Dec; 21(12):1179-1190. PubMed ID: 33218268
[TBL] [Abstract] [Full Text] [Related]
19. Visceral Metastasis: A Prognostic Factor of Survival in Patients with Spinal Metastases.
Lun DX; Chen NW; Feng JT; Yang XG; Xu ZW; Li F; Hu YC
Orthop Surg; 2020 Apr; 12(2):552-560. PubMed ID: 32227458
[TBL] [Abstract] [Full Text] [Related]
20. Nuclear Receptors Are Differentially Expressed and Activated in KAIMRC1 Compared to MCF7 and MDA-MB231 breast cancer Cells.
Nehdi A; Ali R; Alhallaj A; Alzahrani H; Samman N; Mashhour A; Baz O; Barhoumi T; Alghanem B; Khan A; Alriyees L; Boudjelal M
Molecules; 2019 May; 24(11):. PubMed ID: 31141879
[TBL] [Abstract] [Full Text] [Related]
[Next]
